Spero Cataland, MDThe James Cancer Center
- Anemia, Sickle Cell
- Benign Hematology
- Hemolytic-Uremic Syndrome
- Hemophilia A
- Hemophilia B
- Purpura, Thrombotic Thrombocytopenic
- Thrombotic Microangiopathies
- von Willebrand Diseases
Make an Appointment
I’m a hematologist with a focus on non-malignant blood disorders. My specific areas of expertise include platelet abnormalities, blood clotting and bleeding disorders. In addition to treating patients, I serve as professor in the Division of Hematology. In 2014 and 2017, I was rated in the top 10 percent of physicians in the nation for patient satisfaction.
Research is a big part of my career. I established the thrombotic microangiopathy research program, which studies rare blood diseases including thrombotic thrombocytopenic purpura (TTP) and atypical hemolytic-uremic syndrome (HUS). I’m also involved in the design and execution of several international clinical trials.
I enjoy working alongside world-class medical experts at The James to improve patient care. The collaborative environment among physicians and staff at The OSUCCC – James is what truly sets it apart from other cancer centers.
My work has received widespread recognition. I’ve been published in national and international medical journals, including the New England Journal of Medicine, Blood, and, the Journal of Thrombosis and Haemostasis.
Education and Background
Ohio State University College of Medicine
University of Chicago Hospitals
- American Board of Internal Medicine
- American Board of Internal Medicine (Subspecialty: Hematology)
- American Board of Internal Medicine (Subspecialty: Medicine Oncology)
- Department of Internal Medicine
- Division of Hematology
I see patients at
The James Cancer Hospital and Solove Research Institute
460 West 10th Avenue, Columbus, Ohio 43210
JamesCare at University Hospital East
181 Taylor Avenue, Columbus, Ohio 43203
Consulting and Related Relationships
At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the university requires annual disclosures from all faculty members with external interests related to their university responsibilities. As of 3/26/2018, Dr. Cataland has reported relationships with the companies or entities listed below. If you have questions about the relationships listed below, please ask the faculty member. If you have questions about how these relationships are monitored by The Ohio State University Wexner Medical Center, please contact our Compliance Office at 614-293-7802.
- Alexion Pharmaceuticals
- Baxter International, Inc.